For Research Use Only. Not for Human or Veterinary Use.
Overview
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) based on the ACTH(4–10) fragment of adrenocorticotropic hormone, but engineered to keep the neuroactive core while dropping the parent hormone’s corticotropic activity. In research it is studied as a neurotrophic-factor inducer — raising BDNF and NGF — for cognitive and neuroprotection endpoints, and it is typically delivered intranasally. It is a research compound.
🧪Chemical Profile
Property
Value
CAS number
80714-61-0
Class
Synthetic ACTH(4–10) analogue (heptapeptide)
Amino-acid sequence
H-Met-Glu-His-Phe-Pro-Gly-Pro-OH
One-letter code
MEHFPGP (7 aa)
Molecular formula
C₃₇H₅₁N₉O₁₀S
Molecular weight
≈ 813.9 g/mol
Purity (HPLC)
≥ 98%
Appearance
White to off-white lyophilized powder
Semax at a glance
Class
Synthetic ACTH(4–10) analogue
Research status
Preclinical and clinical (Eastern Europe)
Study routes
Intranasal (primary), IV, IM
Half-life
≈ 30 min (intranasal)
Key feature
Neurotrophic-factor (BDNF / NGF) inducer
🔬Mechanism of Action
Semax keeps the CNS-active core of ACTH(4–10) but has no corticotropic (hormonal) activity. Its main studied action is inducing neurotrophic factors — chiefly BDNF and NGF — and the downstream TrkB/CREB signalling associated with neuroplasticity, with additional reported effects on dopamine and serotonin turnover.
Semax has preclinical and clinical (mainly Russian/Ukrainian) literature in stroke and cognition. Representative studies and their focus are named below; specific numerical outcomes are not restated here as claims.
Study type
Research focus
Reference
Rodent ischemia models
Neuroprotection and functional recovery
Semax preclinical literature
Aged-rat cognition
Age-related cognitive decline
Semax preclinical literature
Clinical stroke observation
Recovery in ischemic stroke
Semax clinical literature (Eastern Europe)
Representative reported directions from the literature (qualitative; GLP-1 entries reflect published clinical-trial results, others are reported study directions, not restated as precise product claims):
Reported direction / finding
Context
Reference
Neuroprotection and functional recovery
rodent ischemia models
Semax literature
Raises BDNF/NGF; cognitive effects
rodent cognition
Semax literature
Used in ischemic-stroke recovery research
clinical observation (Eastern Europe)
Semax clinical literature
For laboratory research use only. Not for human or veterinary use, diagnosis, or therapeutic application. Descriptions refer to published research contexts and are not medical or product claims.
⚗️Dosing & Reconstitution Reference
Reconstitution and handling parameters for laboratory research. Not dosing guidance for human use.
Parameter
Reference value
Research dose range (literature)
≈ 200–600 µg per dose (intranasal), in study protocols
Reconstitution solvent
Bacteriostatic water (0.9% benzyl alcohol)
Storage (lyophilized)
−20°C, protected from light
Storage (reconstituted)
2–8°C, up to ~7 days
Do not use
If the solution is cloudy or contains particulates
🛡️Safety Profile
Published research observations, provided for reference only. This material is not for human or veterinary use.
Category
Published observations
Tolerability
Well tolerated in reported studies
Hormonal
No corticotropic activity
Local (intranasal)
Mild, transient nasal irritation possible
Status
For research use only; not for human or veterinary application
📐Physicochemical Properties
Property
Value
Physical state
White to off-white lyophilized powder
Solubility (water)
Freely soluble
pH (reconstituted)
5.0–7.0
Light sensitivity
Moderate
Stability (lyophilized)
≥ 24 months at −20°C
🏭Synthesis & Manufacturing
Semax is a 7-residue peptide made by Fmoc solid-phase synthesis. Its single methionine is oxidation-sensitive, so scavengers are used at cleavage, and the two prolines shape its overall handling.
Step
Detail
Strategy
Fmoc solid-phase peptide synthesis
Resin
Wang resin (C-terminal acid)
Coupling
HBTU / HOBt with DIPEA
Sensitive residue
Met protected against oxidation; scavengers at cleavage
Cleavage
TFA / TIPS / H₂O with thiol scavengers
Purification
Preparative RP-HPLC (C18, TFA/ACN gradient)
Notes: coupling efficiency and complete Fmoc removal are monitored each cycle; hindered or repeated residues (e.g. Arg-Arg) may need double coupling.
Preparative RP-HPLC removes deletion and truncation impurities to reach research-grade purity; salt exchange (lyophilization from dilute HCl) removes residual TFA/acetate.
Critical quality attributes: correct molecular weight and low deletion-peptide content. A single methionine is oxidation-sensitive; protect from air and light.
🔎Analytical Methods
Method
Parameter
Typical result
RP-HPLC (C18, UV 214 nm)
Purity
≥ 98%
HPLC retention
C18, 10–40% B over 25 min
Single main peak
ESI-MS (positive mode)
Identity / mass
[M+H]⁺ ≈ 814 Da
MALDI-TOF
Mass confirmation
[M+H]⁺ ≈ 814 Da
Amino-acid analysis
Composition
Consistent with the stated sequence
LC-MS (extracted ion)
Deletion-peptide impurities
Within specification
Karl Fischer
Water content
< 6%
LAL assay
Endotoxin
Within specification
Ion chromatography
Residual TFA
< 500 ppm
Representative RP-HPLC purity method:
Column: C18, 5 µm, 250 × 4.6 mm
Mobile phase A: 0.1% TFA in water · Mobile phase B: 0.1% TFA in acetonitrile
Gradient: 10–40% B over 25 min · Flow rate: 1.0 mL/min · Detection: UV 214 nm
Confirmatory LC-MS: ESI positive mode ([M+H]⁺ ≈ 814 Da). A single methionine is oxidation-sensitive; protect from air and light.
📈Stability Data
Representative stability behaviour under common storage, handling and formulation conditions.
Condition
Duration
Result
Lyophilized, −20°C, dark
≥ 24 months
No significant degradation (purity > 97%)
Lyophilized, 2–8°C, dark
≥ 12 months
Minimal degradation (purity > 95%)
Lyophilized, 25°C (accelerated)
3 months
< 5% degradation
Reconstituted, 2–8°C, dark
7–14 days
Minor degradation
Reconstituted, 25°C
24–48 h
Use promptly
Light exposure (ICH Q1B)
1.2 M lux·h
Generally light-stable
Freeze–thaw (−20°C ⇄ 25°C)
3 cycles
Acceptable — aliquot to avoid repeats
Keep lyophilized powder cold, dry and light-protected; keep any solution refrigerated and protected from light.
Minimise freeze-thaw cycles; aliquot material used across many sessions.
Key factor: A single methionine is oxidation-sensitive; protect from air and light.
📖Selected References
Semax (ACTH(4–10) analogue) neuroprotection and BDNF/NGF induction literature.
Reviews of regulatory peptides derived from ACTH fragments.
✅Quality & Supply
HPLC ≥ 98% purity with a Certificate of Analysis per batch
Identity confirmed by LC-MS
Research samples through to bulk, with worldwide delivery